Ranibizumab biobetter (Ildong Pharmaceutical)

N/A

Report date: 2024/06/14 13:15:51

Base Information

Drug NameRanibizumab biobetter (Ildong Pharmaceutical)

Drug Alias NameID-13010AIDB0062IDB-0062ID-13010ID-0062

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionVascular endothelial growth factor A inhibitors

TargetsVascular endothelial growth factor A

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIldong Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesIldong Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsMacular Degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A